Patents by Inventor James Doyle

James Doyle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10919624
    Abstract: A system for configuring unmanned aircraft system (UAS) to a structure is disclosed. The structure may be a standing structure such as a tower. A movement system may be configured with the tower. The UASs may be tethered to the movement structure and the movement structure may move with respect to the tower.
    Type: Grant
    Filed: August 4, 2019
    Date of Patent: February 16, 2021
    Assignee: WET
    Inventors: Mark Fuller, Dezso Molnar, James Doyle, John Canavan
  • Publication number: 20200413013
    Abstract: A system and method for altering the visual appearance of moving physical forms is disclosed. The moving physical forms may include solids, liquids, gasses and any combination thereof. The system and method may include video capturing devices for capturing video footage of the moving forms, a controller for altering the captured video footage of the moving forms, and video projecting devices for projecting the altered video footage back onto the moving forms.
    Type: Application
    Filed: February 28, 2020
    Publication date: December 31, 2020
    Inventors: Mark Fuller, James Doyle, Gautam Rangan, Scott Winslow, Isaiah Gernhardt, Ting Zhang
  • Patent number: 10793559
    Abstract: The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.
    Type: Grant
    Filed: September 17, 2019
    Date of Patent: October 6, 2020
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Niall Andrew Anderson, Nicholas Paul Barton, Sebastien Andre Campos, Edward Paul Cannons, Anthony William James Cooper, Kenneth David Down, Kevin James Doyle, Julie Nicole Hamblin, Graham George Adam Inglis, Armelle Le Gall, Vipulkumar Kantibhai Patel, Simon Peace, Andrew Sharpe, Gemma Victoria White
  • Publication number: 20200247765
    Abstract: The present disclosure relates to certain (2S)—N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamide compounds (including pharmaceutically acceptable salts thereof), that inhibit dipeptidyl peptidase 1 (DPP1) activity, to their utility in treating and/or preventing clinical conditions including respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), to their use in therapy, to pharmaceutical compositions containing them and to processes for preparing such compounds.
    Type: Application
    Filed: April 22, 2020
    Publication date: August 6, 2020
    Inventors: Hans Roland LONN, Stephen CONNOLLY, Steven SWALLOW, Staffan PO KARLSSON, Carl-Johan AURELL, John Fritiof PONTÉN, Kevin James DOYLE, Amanda Jane VAN DE POËL, Graham Peter JONES, David Wyn WATSON, Jaqueline Anne MACRITCHIE, Nicholas John PALMER
  • Patent number: 10676983
    Abstract: A fire display that may reside under a viewing window or panel. The display may include a tray or channel along which a fire ball or fire wave may travel. The display includes a gas delivery system.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: June 9, 2020
    Assignee: WET
    Inventors: Mark Fuller, James Doyle, Thomas Marquet, Eric Haik
  • Patent number: 10669245
    Abstract: The present disclosure relates to certain (2S)—N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamide compounds (including pharmaceutically acceptable salts thereof), that inhibit dipeptidyl peptidase 1 (DPP1) activity, to their utility in treating and/or preventing clinical conditions including respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), to their use in therapy, to pharmaceutical compositions containing them and to processes for preparing such compounds.
    Type: Grant
    Filed: March 19, 2019
    Date of Patent: June 2, 2020
    Assignee: ASTRAZENECA AB
    Inventors: Hans Roland Lonn, Stephen Connolly, Steven Swallow, Staffan Po Karlsson, Carl-Johan Aurell, John Fritiof Pontén, Kevin James Doyle, Amanda Jane Van De Poël, Graham Peter Jones, David Wyn Watson, Jaqueline Anne Macritchie, Nicholas John Palmer
  • Publication number: 20200071311
    Abstract: The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.
    Type: Application
    Filed: September 17, 2019
    Publication date: March 5, 2020
    Applicant: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Niall Andrew ANDERSON, Nicholas Paul BARTON, Sebastien Andre CAMPOS, Edward Paul CANNONS, Anthony William James COOPER, Kenneth David DOWN, Kevin James DOYLE, Julie Nicole HAMBLIN, Graham George Adam INGLIS, Armelle LE GALL, Vipulkumar Kantibhai PATEL, Simon PEACE, Andrew SHARPE, Gemma Victoria WHITE
  • Publication number: 20200039643
    Abstract: A system for configuring unmanned aircraft system (UAS) to a structure is disclosed. The structure may be a standing structure such as a tower. A movement system may be configured with the tower. The UASs may be tethered to the movement structure and the movement structure may move with respect to the tower.
    Type: Application
    Filed: August 4, 2019
    Publication date: February 6, 2020
    Inventors: Mark Fuller, Dezso Molnar, James Doyle, John Canavan
  • Publication number: 20200039646
    Abstract: A system for providing a flying craft is disclosed. The craft may include gyroscopes for stability, and rotor blades and/or chambers of lighter-than-air gasses for lift. The craft may be equipped with payloads such as lights, water delivery devices, speaker, wireless power systems and other payloads.
    Type: Application
    Filed: August 4, 2019
    Publication date: February 6, 2020
    Inventors: Mark Fuller, Dezso Molnar, James Doyle, John Canavan
  • Publication number: 20200017455
    Abstract: The present disclosure relates to certain (2S)—N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamide compounds (including pharmaceutically acceptable salts thereof), that inhibit dipeptidyl peptidase 1 (DPP1) activity, to their utility in treating and/or preventing clinical conditions including respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), to their use in therapy, to pharmaceutical compositions containing them and to processes for preparing such compounds.
    Type: Application
    Filed: March 19, 2019
    Publication date: January 16, 2020
    Inventors: Hans Roland LONN, Stephen CONNOLLY, Steven SWALLOW, Staffan PO KARLSSON, Carl-Johan AURELL, John Fritiof PONTÉN, Kevin James DOYLE, Amanda Jane VAN DE POËL, Graham Peter JONES, David Wyn WATSON, Jaqueline Anne MACRITCHIE, Nicholas John PALMER
  • Patent number: 10457674
    Abstract: The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.
    Type: Grant
    Filed: February 10, 2017
    Date of Patent: October 29, 2019
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Niall Andrew Anderson, Nicholas Paul Barton, Sebastien Andre Campos, Edward Paul Cannons, Anthony William James Cooper, Kenneth David Down, Kevin James Doyle, Julie Nicole Hamblin, Graham George Adam Inglis, Armelle Le Gall, Vipulkumar Kantibhai Patel, Simon Peace, Andrew Sharpe, Gemma Victoria White
  • Patent number: 10287258
    Abstract: The present disclosure relates to certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamide compounds (including pharmaceutically acceptable salts thereof), that inhibit dipeptidyl peptidase 1 (DPP1) activity, to their utility in treating and/or preventing clinical conditions including respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), to their use in therapy, to pharmaceutical compositions containing them and to processes for preparing such compounds.
    Type: Grant
    Filed: September 19, 2017
    Date of Patent: May 14, 2019
    Assignee: ASTRAZENECA AB
    Inventors: Hans Roland Lonn, Stephen Connolly, Steven Swallow, Staffan Po Karlsson, Carl-Johan Aurell, John Fritiof Pontén, Kevin James Doyle, Amanda Jane Van De Poël, Graham Peter Jones, David Wyn Watson, Jaqueline Anne Macritchie, Nicholas John Palmer
  • Publication number: 20190063145
    Abstract: A fire display that may reside under a viewing window or panel. The display may include a tray or channel along which a fire ball or fire wave may travel. The display includes a gas delivery system.
    Type: Application
    Filed: August 23, 2018
    Publication date: February 28, 2019
    Inventors: Mark Fuller, James Doyle, Thomas Marquet, Eric Haik
  • Publication number: 20190060944
    Abstract: A water display including a number of pixels or manifolds that may include water nozzles to emit streams of water and/or other utilities such as lighting is described. The water streams may be pixelated so as to provide a high resolution waveform or other choreography. The choreography transitions between waveforms to provide the appearance of a cascading or undulating wave. A tool to design the water display and simulate its appearance is also described.
    Type: Application
    Filed: August 23, 2018
    Publication date: February 28, 2019
    Inventors: Mark Fuller, James Doyle, Markos Okihisa, Gautam Rangan
  • Patent number: 10213711
    Abstract: Described herein are filter assemblies for removing high molecular weight organic components from liquefied petroleum gas, as well as methods for removing high molecular weight components from liquefied petroleum gases. The filter assemblies include an upstream carbon-containing filter media pack and a downstream filter media pack.
    Type: Grant
    Filed: January 5, 2016
    Date of Patent: February 26, 2019
    Assignee: Donaldson Company, Inc.
    Inventors: Karthik Viswanathan, Philip Edward Johnson, Dustin Zastera, James Doyle, Gregory L. LaVallee, Janelle M. Hampton, Andrew J. Dallas
  • Publication number: 20190040051
    Abstract: The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.
    Type: Application
    Filed: February 10, 2017
    Publication date: February 7, 2019
    Inventors: Niall Andrew ANDERSON, Nicholas Paul BARTON, Sebastien Andre CAMPOS, Edward Paul CANNONS, Anthony William James COOPER, Kenneth David DOWN, Kevin James DOYLE, Julie Nicole HAMBLIN, Graham George Adam INGLIS, Armelle LE GALL, Vipulkumar Kantibhai PATEL, Simon PEACE, Andrew SHARPE, Gemma Victoria WHITE
  • Patent number: 10199939
    Abstract: A multi-phase switching power converter includes a panic mode detector that triggers the activation of each phase in an open-loop mode of operation in which an open-loop duty cycle is used that is greater than a closed-loop duty cycle used during closed-loop operation for the active phases.
    Type: Grant
    Filed: July 16, 2018
    Date of Patent: February 5, 2019
    Assignee: DIALOG SEMICONDUCTOR (UK) LIMITED
    Inventors: Kevin Yi Cheng Chang, James Doyle, Qing Li, Xiaoying Yu, Ibiyemi Omole, Jonathon Stiff, Erik Mentze, Aysel Yildiz
  • Patent number: 10187148
    Abstract: A method for connecting a number of users with at least one signal bearing optical fiber (1101÷z; 2101÷5) contained in an optical cable (105; 205) is proposed.
    Type: Grant
    Filed: September 16, 2014
    Date of Patent: January 22, 2019
    Assignee: PRYSMIAN S.p.A.
    Inventors: Daniel James Doyle, Richard Earnest Beattie
  • Patent number: D863518
    Type: Grant
    Filed: June 10, 2015
    Date of Patent: October 15, 2019
    Assignee: WET
    Inventors: Mark Fuller, Susan Fuller, James Doyle, Riae Yoo, Dezso Molnar, Scott Winslow
  • Patent number: PP32437
    Abstract: A new and distinct variety of fig (Ficus carica) tree named ‘4-19’, characterized by its large size and dark purple skin, as well as its productivity and regular bearing. The tree produces two crops, both the breba first crop and the productive second, or main, crop. The fruit eye is usually small, the fruit skin and meat are moderately thick and durable, and the fruit pulp has an attractive reddish color, is fine-textured, and is sweet and rich in flavor. The fruit appears to hold its size later into the season than other commercial varieties of figs, thus extending the season for prime size and quality figs.
    Type: Grant
    Filed: November 19, 2019
    Date of Patent: November 10, 2020
    Inventor: James Doyle